A new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union €157 billion a year in actual health care expenses and lost earning potential, according to a new series of studies published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism.
Global experts in this field concluded that infertility and male reproductive dysfunctions, birth defects, obesity, diabetes, cardiovascular disease, and neurobehavioral and learning disorders were among the conditions than can be attributed in part to exposure to endocrine-disrupting chemicals (EDCs).
EDCs mimic, block or interfere with the body’s hormones. EDCs include bisphenol A (BPA) found in till receipts and food can linings, certain phthalates found in plastic products and cosmetics, flame retardants and pesticides such as chlorpyrifos.
Comments